Baron Discovery Fund delivered a 2.96% return in the first quarter of 2026, underperforming its Russell 2000 benchmark by 220 basis points. The small-cap focused fund saw headwinds from its concentrated portfolio of growth and innovation-oriented companies as investors rotated toward value and dividend-paying stocks during a period of economic uncertainty.
The Russell 2000 gained 5.16% in Q1, significantly outpacing the fund's performance. Baron's managers attributed this lag to sector allocation challenges. Technology and healthcare holdings, which typically comprise a large portion of the portfolio, faced selling pressure as market participants reassessed growth valuations amid rising interest rate expectations and tightening credit conditions.
Notable positions in the fund's portfolio included exposure to smaller biotechnology firms and software companies betting on artificial intelligence adoption. Several of these names declined sharply during the quarter as investors demanded proof of profitability rather than growth potential. The fund's largest detractors included companies with elevated burn rates and extended paths to cash flow positivity.
On the positive side, a handful of industrials and specialty finance names rallied as investors anticipated stronger economic data. Baron's exposure to these cyclical sectors provided some offset to the technology weakness, though not enough to match broader small-cap gains.
Looking forward, Baron's management team expects continued volatility in small-cap equities as the Federal Reserve navigates inflation dynamics and labor market strength. The fund maintains its contrarian stance, believing current valuations in high-growth, early-stage companies present compelling long-term entry points despite near-term pressure.
The portfolio's 65% turnover rate reflects active rebalancing as managers identified new opportunities in beaten-down growth stocks. Baron added positions in select fintech disruptors and expanded holdings in software-as-a-service businesses trading at depressed multiples relative to historical averages.
Investors in small-cap growth funds face a critical decision point. The Russell 2000 index remains volatile, and fund performance will hinge on whether the current rotation toward value proves temporary or structural. Baron's contrarian positioning could reward patient investors if growth stocks regain favor, though near-term headwinds persist.
The Baron Discovery Fund (BDMVX), Russell 2000 Index (RUT), and small-cap growth equities face ongoing pressure from higher discount rates and economic uncertainty. Monitor Fed policy communications and Q1 earnings reports from small-cap technology and healthcare companies for signals on whether growth valuations find support.